Is it possible to test for biomarkers in lung cancer on a national scale?


This is the first video in our series from a program filmed directly from ASCO 2013. Drs. Nate Pennell, Mary Pinder, and Jack West discuss the Biomarkers France trial of testing on a national scale for clinically relevant biomarkers in advanced non-small cell lung cancer (NSCLC).



>> Discuss this GRACEcast Video in the GRACE Discussion Forums


How do we manage a "mixed response" to lung cancer treatment?


Here's a brief video that explains my approach to a so-called "mixed response" to treatment for a lung cancer.  


There isn't a formal teaching or "best answer" about how to approach this issue, but what I explain here is a common and I think very sensible strategy for a still controversial clinical setting (if I do say so myself).  I'd welcome your comments.

I hope you find it helpful if you or someone you care about faces this situation.

Dr. Weiss's "Highlights in Lung Cancer, 2011": CT Screening & Optimal Management of Elderly Patients with Advanced NSCLC


This is the third and final part of Dr. Weiss's presentation on "Highlights in Lung Cancer, 2011".  After focusing on developments in relatively narrow subpopulations with distinct molecular markers in the first two parts of his webinar, Dr.

Subscribe to GRACE